Merck & Co., Inc. (NYSE:MRK) is included among the 16 Best Dividend Stocks with Rising Payouts. On February 13, Deutsche Bank ...

Fintel reports that on February 20, 2026, Barclays initiated coverage of Merck (NYSE:MRK) with a Overweight recommendation. Analyst Price Forecast Suggests 2.67% Downside As of February 3, 2026, the ...

Merck & Co. MRK and Bristol Myers Squibb BMY are major global drugmakers with expansive, diversified portfolios. Merck stands ...

Merck is sending hazardous waste from its Riverside Cherokee plant off-site for treatment and disposal, according to the Pennsylvania Department of Environmental Protection.

Futures are trading lower as we wrap up the holiday-shortened week that gave us a little taste of just about everything. While Walmart posted results that beat expectations, its forward guidance and ...

Gilead Sciences, Inc. shares have risen more than 43% over the past year. Click here to find out why GILD stock is a Sell.

Four years after he resigned as Chief Medical Officer at Novartis in the wake of a restructuring at the Big Pharma, John Tsai ...

Merck (MRK) pharma stock has been on a climb for some time now but has recently stalled near a familiar breakdown zone ...

Interest in the use and impacts of glucagon-like peptide-1 receptor agonists in rheumatology has exploded over the past year, a trend that appeared to crescendo at ACR Convergence 2025. There, ...

Investing.com -- Barclays launched coverage of U.S. large-cap biopharmaceutical companies, arguing the sector could regain investor attention in an uncertain macro backdrop, while naming Eli Lilly ...

DURHAM, NC, UNITED STATES, February 16, 2026 /EINPresswire.com/ -- LeChase Construction Services has strengthened its ...

Investigators sought to determine whether adjuvant pembrolizumab is associated with the risk of developing subsequent cutaneous malignant neoplasms in patients with high-risk stage II melanoma ...